COVID-19 Vaccine Coverage and Factors Associated with Vaccine Hesitancy: A Cross-Sectional Survey in the City of Kinshasa, Democratic Republic of Congo

被引:0
|
作者
Akilimali, Pierre Z. [1 ,2 ]
Egbende, Landry [2 ]
Kayembe, Dynah M. [1 ]
Kabasubabo, Francis [1 ]
Kazenza, Benito [2 ]
Botomba, Steve [2 ]
Tran, Nguyen Toan [3 ,4 ]
Mashinda, Desire K. [5 ]
机构
[1] Univ Kinshasa, Patrick Kayembe Res Ctr, Kinshasa Sch Publ Hlth, POB 11850, Kinshasa, Rep Congo
[2] Univ Kinshasa, Kinshasa Sch Publ Hlth, Dept Nutr, POB 11850, Kinshasa, Rep Congo
[3] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, POB 123, Sydney, NSW 2007, Australia
[4] Univ Geneva, Fac Med, Rue Michel-Servet 1, CH-1206 Geneva, Switzerland
[5] Univ Kinshasa, Kinshasa Sch Publ Hlth, Dept Biostat & Epidemiol, POB 11850, Kinshasa, Rep Congo
关键词
COVID-19; vaccine hesitancy; associated factors; ACCEPTANCE;
D O I
10.3390/vaccines12020188
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccination against COVID-19 has been the main strategy used by most countries to limit the spread of the virus. However, vaccine uptake has been low in Africa, leading to the implementation of several interventions in order to improve vaccine coverage. This study was conducted due to the lack of information about COVID-19 vaccine coverage and the factors associated with vaccine hesitancy. This cross-sectional study was carried out in Kinshasa city using multi-stage random sampling. A total of 2160 households were included in this study. The data were analyzed using Stata 17 software. The means and standard deviations were computed for continuous data that followed a normal distribution, whereas proportions together with their 95% confidence intervals (CIs) were computed for categorical variables. The connections between dependent variables and each independent variable were tested using either Pearson's chi-square test or Fisher's exact test. The logistic regression method was employed to determine the factors that are linked to hesitation in obtaining the COVID-19 immunization. The majority of respondents were aged between 25 and 34 and 35 and 49 (28.9%). During this study, 15% (95% CI [13.25-17.9]) of respondents had received at least one dose of the COVID-19 vaccine. The prevalence of vaccine hesitancy was 67% (CI95%:64.9-69.1). Among the reasons given for refusing to be vaccinated, most respondents cited concerns about the vaccine being unsafe or causing adverse reactions (45%). Among the reasons given for accepting the vaccine, 26% thought that the vaccine prevented superinfection. The factors associated with hesitancy toward the COVID-19 vaccine were female gender, an age of less than 35 years, and living in non-slum households. Despite the interventions implemented across the country, the reluctance to be vaccinated remains a problem; this could lead to poor health outcomes, especially among the elderly and those with pre-existing conditions. It is important to step up awareness-raising campaigns in the community in order to increase the uptake of vaccination.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [31] COVID-19 vaccine hesitancy in Ethiopia in 2021: a multicenter cross-sectional study
    Erega, Besfat Berihun
    Ferede, Wassie Yazie
    Sisay, Fillorenes Ayalew
    Tiruneh, Gebrehiwot Ayalew
    Ayalew, Abeba Belay
    Malka, Erean shigign
    Tassew, Habtamu Abie
    Alemu, Asrat
    IJID REGIONS, 2023, 6 : 120 - 124
  • [32] COVID-19 Parental Vaccine Hesitancy in Romania: Nationwide Cross-Sectional Study
    Manolescu, Loredana Sabina Cornelia
    Zaharia, Corneliu Nicolae
    Dumitrescu, Anca Irina
    Prasacu, Irina
    Radu, Mihaela Corina
    Boeru, Adrian Calin
    Boidache, Liliana
    Nita, Irina
    Necsulescu, Andrei
    Medar, Cosmin
    Cristache, Corina Marilena
    Chivu, Razvan Daniel
    VACCINES, 2022, 10 (04)
  • [33] COVID-19 vaccine hesitancy in the UK: a longitudinal household cross-sectional study
    Chaudhuri, Kausik
    Chakrabarti, Anindita
    Chandan, Joht Singh
    Bandyopadhyay, Siddhartha
    BMC PUBLIC HEALTH, 2022, 22 (01)
  • [34] Global decline in vaccine coverage; COVID-19 Vaccine Hesitancy
    Laaser, U.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [35] Vaccine hesitancy in Austria A cross-sectional survey
    Sandhofer, Michael J.
    Robak, Oliver
    Frank, Herbert
    Kulnig, Johannes
    WIENER KLINISCHE WOCHENSCHRIFT, 2017, 129 (1-2) : 59 - 64
  • [36] Determinants of COVID-19 Vaccine Hesitancy During the Pandemic: A Cross-Sectional Survey in the Canton of Vaud, Switzerland
    Veys-Takeuchi, Caroline
    Nussle, Semira Gonseth
    Estoppey, Sandrine
    Zuppinger, Claire
    Dupraz, Julien
    Pasquier, Jerome
    Faivre, Vincent
    Scuderi, Renzo
    Vassaux, Sophie
    Bochud, Murielle
    D'Acremont, Valerie
    INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2022, 67
  • [37] Determinants of Parental Vaccine Hesitancy During the COVID-19 Era in Saudi Arabia: A Cross-Sectional Survey
    Aljerian, Khaldoon
    AlMadi, Hamad
    AlMadi, Nawaf H.
    AlKahtani, Abdulaziz
    AlGhamdi, Hussam
    Al-Ghamdi, Ahmed
    Al-Assaf, Abdulaziz
    AlSubaie, Abdulaziz
    Temsah, Mohamad-Hani
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [38] Political Ideologies, Government Trust, and COVID-19 Vaccine Hesitancy in South Korea: A Cross-Sectional Survey
    Park, Hyun Kyung
    Ham, Ji Hye
    Jang, Deok Hyun
    Lee, Jin Yong
    Jang, Won Mo
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (20)
  • [39] COVID-19 vaccine hesitancy, acceptance and informational needs in an Australian cancer population: a cross-sectional survey
    Scanlon, Brighid
    Wyld, David
    Firman, Paul
    Nakagaki, Midori
    Durham, Jo
    Kennedy, Glen
    Moran, Paul
    Smith, Michael
    Gavin, Nicole
    AUSTRALIAN HEALTH REVIEW, 2023, 47 (01) : 110 - 118
  • [40] Parental concerns and vaccine hesitancy against COVID-19 vaccination for children in Greece: A cross-sectional survey
    Steletou, E.
    Giannouchos, T.
    Dimitriou, G.
    Karatza, A.
    Sinopidis, X.
    Maltezou, H. C.
    Souliotis, K.
    Gkentzi, D.
    VACCINE, 2024, 42 (03) : 448 - 454